Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18646387 | 0.99 | FFAR4 (0.31) | FFAR4TSHR | |
| SCHEMBL21231963 | 0.96 | FFAR4 (0.32) | FFAR4PPARD | |
| SCHEMBL21115534 | 0.96 | FFAR4 (0.32) | FFAR4PPARD | |
| SCHEMBL21231981 | 0.93 | FFAR4 (0.32) | FFAR4TSHR | |
| SCHEMBL21115591 | 0.93 | FFAR4 (0.32) | FFAR4TSHR | |
| SCHEMBL21231954 | 0.92 | TSHR (0.30) | TSHR | |
| SCHEMBL21231998 | 0.92 | TSHR (0.30) | TSHR | |
| SCHEMBL21232211 | 0.92 | TSHR (0.30) | TSHR | |
| SCHEMBL21115971 | 0.92 | FFAR4 (0.32) | FFAR4TSHR | |
| SCHEMBL21231958 | 0.92 | FFAR4 (0.32) | FFAR4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3521401-B1 | COMPOUNDS FOR HOMEOTROPIC ALIGNMENT OF LIQUID CRYSTALINE MEDIA | MERCK PATENT GMBH (DE) | 2021-04-21 | — | — | EP | disclosed |
| US-20190241809-A1 | COMPOUNDS FOR THE HOMEOTROPIC ALIGNMENT OF LIQUID-CRYSTALLINE MEDIA | MERCK PATENT GMBH (DE) | 2019-08-08 | — | — | US | disclosed |
| EP-3521401-A1 | COMPOUNDS FOR HOMEOTROPIC ALIGNMENT OF LIQUID CRYSTALINE MEDIA | Merck Patent GmbH (DE) | 2019-08-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190241809-A1 | COMPOUNDS FOR THE HOMEOTROPIC ALIGNMENT OF LIQUID-CRYSTALLINE MEDIA | NEFM, MDN1, VCL | FFAR4 2059/4885TSHR 4063/4885PPARD 4171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.